Pulse Biosciences (PLSE)

• Market cap: $1.06B
• 1 day: -2.53%
• 5 days: -9.00%
• 1 month: -6.35%
• 3 months: -7.18%
• 6 months: -10.65%
• Year to date: -11.35%
• 1 year: 29.26%
• 5 years: 81.47%
• 10 years: 278.18%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Employees: 75

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

157% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 7

44% more call options, than puts

Call options by funds: $1.49M | Put options by funds: $1.03M

14% more funds holding

Funds holding: 73 [Q4 2024] → 83 (+10) [Q1 2025]

0.47% less ownership

Funds ownership: 9.7% [Q4 2024] → 9.23% (-0.47%) [Q1 2025]

12% less capital invested

Capital invested by funds: $104M [Q4 2024] → $91.4M (-$12.5M) [Q1 2025]

21% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 29